Fabio L. Fontes

718 total citations
8 papers, 366 citations indexed

About

Fabio L. Fontes is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Fabio L. Fontes has authored 8 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Fabio L. Fontes's work include Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (5 papers) and Cancer therapeutics and mechanisms (3 papers). Fabio L. Fontes is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (5 papers) and Cancer therapeutics and mechanisms (3 papers). Fabio L. Fontes collaborates with scholars based in United States, Australia and Singapore. Fabio L. Fontes's co-authors include Dean C. Crick, Debbie C. Crans, Ashutosh Upadhyay‬, Mary Jackson, Scott G. Franzblau, Wěi Li, E. Jeffrey North, Anna E. Grzegorzewicz, Yuehong Wang and Richard Lee and has published in prestigious journals such as Langmuir, Antimicrobial Agents and Chemotherapy and Dalton Transactions.

In The Last Decade

Fabio L. Fontes

8 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabio L. Fontes United States 7 234 210 144 50 39 8 366
Devayani P. Bhave United States 7 134 0.6× 204 1.0× 126 0.9× 40 0.8× 20 0.5× 8 361
Smriti Smriti India 8 134 0.6× 176 0.8× 120 0.8× 92 1.8× 80 2.1× 18 446
Crystal M. Darby United States 8 206 0.9× 185 0.9× 155 1.1× 56 1.1× 55 1.4× 9 364
Priya Ragunathan Singapore 14 262 1.1× 468 2.2× 141 1.0× 45 0.9× 31 0.8× 35 576
Dirk A. Lamprecht United States 11 403 1.7× 371 1.8× 276 1.9× 121 2.4× 42 1.1× 15 699
Anne Drumond Villela Brazil 14 260 1.1× 244 1.2× 142 1.0× 31 0.6× 128 3.3× 32 453
María‐Natalia Lisa France 11 162 0.7× 276 1.3× 105 0.7× 227 4.5× 22 0.6× 25 556
Peter C. Ray United Kingdom 12 284 1.2× 256 1.2× 179 1.2× 52 1.0× 162 4.2× 21 556
Ameeruddin Nusrath Unissa India 9 273 1.2× 159 0.8× 194 1.3× 40 0.8× 67 1.7× 18 394
Antonella De Montis Italy 12 197 0.8× 173 0.8× 113 0.8× 28 0.6× 258 6.6× 24 548

Countries citing papers authored by Fabio L. Fontes

Since Specialization
Citations

This map shows the geographic impact of Fabio L. Fontes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio L. Fontes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio L. Fontes more than expected).

Fields of papers citing papers by Fabio L. Fontes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio L. Fontes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio L. Fontes. The network helps show where Fabio L. Fontes may publish in the future.

Co-authorship network of co-authors of Fabio L. Fontes

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio L. Fontes. A scholar is included among the top collaborators of Fabio L. Fontes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio L. Fontes. Fabio L. Fontes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fontes, Fabio L., et al.. (2024). Pyrazinoic acid, the active form of the anti-tuberculosis drug pyrazinamide, and aromatic carboxylic acid analogs are protonophores. Frontiers in Molecular Biosciences. 11. 1350699–1350699. 5 indexed citations
2.
Fontes, Fabio L., et al.. (2020). The Acid–Base Equilibrium of Pyrazinoic Acid Drives the pH Dependence of Pyrazinamide-Induced Mycobacterium tuberculosis Growth Inhibition. ACS Infectious Diseases. 6(11). 3004–3014. 7 indexed citations
3.
Islam, M. Nurul, Santosh Kumar, Fabio L. Fontes, et al.. (2018). Mechanism of Fluorinated Anthranilate-Induced Growth Inhibition in Mycobacterium tuberculosis. ACS Infectious Diseases. 5(1). 55–62. 20 indexed citations
4.
Cook, Gregory M., Kiel Hards, Elyse Dunn, et al.. (2017). Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions. Microbiology Spectrum. 5(3). 93 indexed citations
5.
Fontes, Fabio L., et al.. (2016). Differences in Interactions of Benzoic Acid and Benzoate with Interfaces. Langmuir. 32(37). 9451–9459. 11 indexed citations
6.
Upadhyay‬, Ashutosh, Fabio L. Fontes, Mercedes Gonzalez‐Juarrero, et al.. (2015). Partial Saturation of Menaquinone in Mycobacterium tuberculosis: Function and Essentiality of a Novel Reductase, MenJ. ACS Central Science. 1(6). 292–302. 51 indexed citations
7.
Li, Wěi, Ashutosh Upadhyay‬, Fabio L. Fontes, et al.. (2014). Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 58(11). 6413–6423. 154 indexed citations
8.
Fontes, Fabio L., et al.. (2013). Raft localization of Type I Fcε receptor and degranulation of RBL-2H3 cells exposed to decavanadate, a structural model for V2O5. Dalton Transactions. 42(33). 11912–11912. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026